The Accidental Breakthrough: How a Supply Crisis Made Surgery Safer

THE BRONX, NY – September 15, 2026 – For decades, the steady drip of an intravenous fluid bag has been an unquestioned constant in the operating room, a tool believed to be essential for maintaining a patient’s stability during surgery. But a groundbreaking study published today in JAMA Network Open by researchers at Montefiore Einstein turns that long-held assumption on its head, revealing that less can, in fact, be much more.

In a remarkable case of innovation born from necessity, the study demonstrates that significantly reducing IV fluid administration during elective surgeries is not only safe but is linked to better patient outcomes, including fewer infections and lower hospital readmission rates. The findings represent a potential paradigm shift in surgical care, one that was discovered not in a pristine lab, but in the crucible of a real-world crisis.

From Crisis Comes Clarity

It began with a disaster. In 2024, Hurricane Helene tore through key pharmaceutical manufacturing regions, triggering a nationwide shortage of sterile IV fluids—a basic but critical hospital supply. As health systems across the country scrambled to conserve their dwindling stocks, a team of anesthesiologists at Montefiore Health System in New York saw a unique opportunity.

Instead of simply rationing supplies, they responded with a methodical, system-wide intervention. The institution implemented a 12-step fluid conservation program that went beyond simple cutbacks. It involved a strategic combination of enhanced staff education, a switch to smaller fluid bags to discourage over-administration, and a greater emphasis on oral hydration for patients before their procedures. The results were dramatic: a 75% decrease in the volume of IV fluids used during surgery for nearly 27,000 patients.

This forced adaptation created the conditions for a large-scale “natural experiment.” The researchers were able to compare the outcomes of these 27,000 patients with a control group of 12,000 patients who had undergone similar elective surgeries before the shortage began. This wasn’t a theoretical model; it was a powerful, real-world test of a fundamental clinical practice.

Challenging a Decades-Old Practice

The practice of hydrating patients during surgery has long been more art than science. For years, a liberal approach—giving patients generous amounts of fluid—was common, based on the theory that it helped protect organ function and maintain blood pressure. However, a growing body of evidence has begun to suggest that this “more is better” philosophy could have a downside, potentially contributing to complications like tissue swelling and impaired organ function. Yet, without a clear consensus or large-scale data, clinical habits have been slow to change.

The Montefiore Einstein study provides the kind of robust evidence that can shift a paradigm. Its massive scale and real-world setting give its conclusions a weight that smaller, more controlled trials often lack. It suggests that the standard practice in many operating rooms may not be the optimal one.

“Our study demonstrates how a health system can respond rapidly to a national supply crisis in an innovative fashion while maintaining patient safety,” said Dr. Matthias Eikermann, a co-author of the study and Chair of the Department of Anesthesiology at Montefiore Einstein. “These findings have had a lasting impact at Montefiore Einstein and have relevance for future shortages. In the meantime, we look forward to doing further research that may help to inform best practices in intraoperative fluid usage across the country.”

A Tangible Difference for Patients

Beyond the clinical statistics, the study’s findings point to a tangible difference in the patient experience. The data showed that the group receiving less IV fluid had significantly lower rates of Foley catheter insertion. For a patient, this means avoiding an uncomfortable invasive procedure and, more importantly, reducing the risk of a painful and potentially dangerous urinary tract infection (UTI), a common hospital-acquired complication.

The most compelling finding, however, may be the decrease in 30-day hospital readmissions. This key metric is a powerful indicator of a patient’s overall recovery. A lower readmission rate means that patients weren't just discharged; they went home healthier and stayed healthier, avoiding the physical, emotional, and financial toll of a return trip to the hospital. It’s a clear signal that the less-is-more approach contributed to a more resilient and complete recovery.

The Blueprint for a New Standard?

The implications of the study are poised to ripple across the country. In an era where healthcare is intensely focused on both value and quality, a strategy that simultaneously improves patient outcomes and preserves resources is the ultimate goal. The economic benefits are twofold: direct cost savings from using fewer IV fluid bags and administration kits, and far more substantial indirect savings from preventing costly complications and readmissions, which often incur financial penalties for hospitals.

Because Montefiore’s intervention was built on practical, low-tech changes like staff training and using smaller bags, it offers a highly scalable and accessible model for other hospitals to follow, even those without the resources for complex monitoring equipment. The research provides a powerful argument for re-evaluating deep-seated institutional habits and empowering clinicians to challenge the status quo.

In turning a supply chain failure into a clinical breakthrough, the New York-based health system has provided more than just data. It has created a blueprint for how to find opportunity in adversity, proving that sometimes the most profound innovations aren’t found in a new technology, but in the courage to question what we think we already know.